BOSTON Bio 2000 broke all previous records for attendance and involvement by scientists, academic researchers, company executives, patient advocates, government officials and investment experts.
By far, this was the best attended and most successful international meeting and exhibition the biotechnology industry has ever held, said Carl Feldbaum, President of the Biotechnology Industry Organization (BIO) which sponsored the event. The number of attendees almost doubled from last year, and we saw a dramatic rise in overseas participants and exhibitors. I want to thank Mayor Menino and the City of Boston for all of their help and cooperation in making Bio 2000 such an overwhelming success.
Feldbaum said that Boston lived up to its reputation as a venue for informed dialogue and spirited debate. Boston has a long tradition of spirited public discourse about the issues of the day. As our industry continues its phenomenal growth, we are recommitting ourselves to a new level of public education about the benefits and challenges facing this industry. Feldbaum said.
Conference Facts:
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.